2023
Provider and administrator attitudes and experiences with implementing telebuprenorphine during the COVID-19 pandemic: a mixed-methods survey
Tofighi B, Lopez R, Araujo G, Lee J, Samuels E, Wightman R, Butner J. Provider and administrator attitudes and experiences with implementing telebuprenorphine during the COVID-19 pandemic: a mixed-methods survey. Journal Of Substance Use 2023, 29: 347-353. PMID: 39005537, PMCID: PMC11244434, DOI: 10.1080/14659891.2023.2166609.Peer-Reviewed Original ResearchPatient-level factorsPrior authorization requirementsBehavioral health providersCompletion of referralsCOVID-19 pandemicSame-day visitsClinical workflowBuprenorphine prescriptionsPatient receiptVideo visitsSpecialty treatmentBuprenorphine providersStaff redeploymentClinical careCommunity pharmaciesHealth providersAvailable pharmacyAdministrator participantsLaboratory servicesMixed-methods studyMixed-methods surveyProgram entryCOVID-19Considerable heterogeneityText messaging
2021
Low Threshold Telemedicine-based Opioid Treatment for Criminal Justice Involved Adults During the COVID-19 Pandemic: A Case Report
Flavin L, Tofighi B, Krawczyk N, Schatz D, McNeely J, Butner J. Low Threshold Telemedicine-based Opioid Treatment for Criminal Justice Involved Adults During the COVID-19 Pandemic: A Case Report. Journal Of Addiction Medicine 2021, 16: e59-e61. PMID: 35120069, PMCID: PMC8815634, DOI: 10.1097/adm.0000000000000836.Peer-Reviewed Original ResearchConceptsNew York City jailsCriminal justiceCity jailsEarly release programsOpioid use disorderOffice-based opioid treatment programSevere opioid use disorderCOVID-19 pandemicCounty jailPost-releaseBuprenorphine clinicUse disorderJailRelease programsRates of opioid overdose deathsBuprenorphine-naloxoneOpioid overdose deathsTreatment programsJusticeTemporary housingOverdose deathsBuprenorphine providersTele-conferencingCOVID-19Opioid treatment programs
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply